https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Intolerance to high pacing rates was reported in only one patient (1.6%) and was easily resolved by reprogramming the maximum CLS pacing rate. We did not find evidence of suspected sinus or atrioventricular node dysfunction in the BIOSync CLS patients. The benefit of pacing should be ascribed to pacing prevention of pure vasovagal episodes. CLS algorithm modulated pacing rates over a wide frequency range, consistently competing with sinus node. We did not find evidence of suspected sinus or atrioventricular node dysfunction
Beğen
Yorum Yap
Paylaş
